Report Detail

Medical Devices & Consumables COVID-19 Impact on Global Intravitreal (IVT) Injectables Market Insights, Forecast to 2026

  • RnM3990595
  • |
  • 05 June, 2020
  • |
  • Global
  • |
  • 111 Pages
  • |
  • QYResearch
  • |
  • Medical Devices & Consumables

Intravitreal (IVT) Injectables market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Intravitreal (IVT) Injectables market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Intravitreal (IVT) Injectables market is segmented into
Anti-VEGF
Corticosteroids
Antibiotics
Antivirals
Antifungals

Segment by Application, the Intravitreal (IVT) Injectables market is segmented into
Hospital Pharmacies
Retail Pharmacies
Drug Stores
Mail Order Pharmacies
Others

Regional and Country-level Analysis
The Intravitreal (IVT) Injectables market is analysed and market size information is provided by regions (countries).
The key regions covered in the Intravitreal (IVT) Injectables market report are North America, Europe, China and Japan. It also covers key regions (countries), viz, the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of production capacity, price and revenue for the period 2015-2026.
Competitive Landscape and Intravitreal (IVT) Injectables Market Share Analysis

Intravitreal (IVT) Injectables market competitive landscape provides details and data information by manufacturers. The report offers comprehensive analysis and accurate statistics on production capacity, price, revenue of Intravitreal (IVT) Injectables by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on production, revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue, and the production capacity, price, revenue generated in Intravitreal (IVT) Injectables business, the date to enter into the Intravitreal (IVT) Injectables market, Intravitreal (IVT) Injectables product introduction, recent developments, etc.
The major vendors covered:
Regeneron Pharmaceuticals
Bausch & Lomb
Novartis
Allergan
Alimera Sciences
ThromboGenics
Bristol-Myers Squibb


1 Study Coverage

  • 1.1 Intravitreal (IVT) Injectables Product Introduction
  • 1.2 Key Market Segments in This Study
  • 1.3 Key Manufacturers Covered: Ranking of Global Top Intravitreal (IVT) Injectables Manufacturers by Revenue in 2019
  • 1.4 Market by Type
    • 1.4.1 Global Intravitreal (IVT) Injectables Market Size Growth Rate by Type
    • 1.4.2 Anti-VEGF
    • 1.4.3 Corticosteroids
    • 1.4.4 Antibiotics
    • 1.4.5 Antivirals
    • 1.4.6 Antifungals
  • 1.5 Market by Application
    • 1.5.1 Global Intravitreal (IVT) Injectables Market Size Growth Rate by Application
    • 1.5.2 Hospital Pharmacies
    • 1.5.3 Retail Pharmacies
    • 1.5.4 Drug Stores
    • 1.5.5 Mail Order Pharmacies
    • 1.5.6 Others
  • 1.6 Coronavirus Disease 2019 (Covid-19): Intravitreal (IVT) Injectables Industry Impact
    • 1.6.1 How the Covid-19 is Affecting the Intravitreal (IVT) Injectables Industry
      • 1.6.1.1 Intravitreal (IVT) Injectables Business Impact Assessment - Covid-19
      • 1.6.1.2 Supply Chain Challenges
      • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
    • 1.6.2 Market Trends and Intravitreal (IVT) Injectables Potential Opportunities in the COVID-19 Landscape
    • 1.6.3 Measures / Proposal against Covid-19
      • 1.6.3.1 Government Measures to Combat Covid-19 Impact
      • 1.6.3.2 Proposal for Intravitreal (IVT) Injectables Players to Combat Covid-19 Impact
  • 1.7 Study Objectives
  • 1.8 Years Considered

2 Executive Summary

  • 2.1 Global Intravitreal (IVT) Injectables Market Size Estimates and Forecasts
    • 2.1.1 Global Intravitreal (IVT) Injectables Revenue Estimates and Forecasts 2015-2026
    • 2.1.2 Global Intravitreal (IVT) Injectables Production Capacity Estimates and Forecasts 2015-2026
    • 2.1.3 Global Intravitreal (IVT) Injectables Production Estimates and Forecasts 2015-2026
  • 2.2 Global Intravitreal (IVT) Injectables Market Size by Producing Regions: 2015 VS 2020 VS 2026
  • 2.3 Analysis of Competitive Landscape
    • 2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
    • 2.3.2 Global Intravitreal (IVT) Injectables Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    • 2.3.3 Global Intravitreal (IVT) Injectables Manufacturers Geographical Distribution
  • 2.4 Key Trends for Intravitreal (IVT) Injectables Markets & Products
  • 2.5 Primary Interviews with Key Intravitreal (IVT) Injectables Players (Opinion Leaders)

3 Market Size by Manufacturers

  • 3.1 Global Top Intravitreal (IVT) Injectables Manufacturers by Production Capacity
    • 3.1.1 Global Top Intravitreal (IVT) Injectables Manufacturers by Production Capacity (2015-2020)
    • 3.1.2 Global Top Intravitreal (IVT) Injectables Manufacturers by Production (2015-2020)
    • 3.1.3 Global Top Intravitreal (IVT) Injectables Manufacturers Market Share by Production
  • 3.2 Global Top Intravitreal (IVT) Injectables Manufacturers by Revenue
    • 3.2.1 Global Top Intravitreal (IVT) Injectables Manufacturers by Revenue (2015-2020)
    • 3.2.2 Global Top Intravitreal (IVT) Injectables Manufacturers Market Share by Revenue (2015-2020)
    • 3.2.3 Global Top 10 and Top 5 Companies by Intravitreal (IVT) Injectables Revenue in 2019
  • 3.3 Global Intravitreal (IVT) Injectables Price by Manufacturers
  • 3.4 Mergers & Acquisitions, Expansion Plans

4 Intravitreal (IVT) Injectables Production by Regions

  • 4.1 Global Intravitreal (IVT) Injectables Historic Market Facts & Figures by Regions
    • 4.1.1 Global Top Intravitreal (IVT) Injectables Regions by Production (2015-2020)
    • 4.1.2 Global Top Intravitreal (IVT) Injectables Regions by Revenue (2015-2020)
  • 4.2 North America
    • 4.2.1 North America Intravitreal (IVT) Injectables Production (2015-2020)
    • 4.2.2 North America Intravitreal (IVT) Injectables Revenue (2015-2020)
    • 4.2.3 Key Players in North America
    • 4.2.4 North America Intravitreal (IVT) Injectables Import & Export (2015-2020)
  • 4.3 Europe
    • 4.3.1 Europe Intravitreal (IVT) Injectables Production (2015-2020)
    • 4.3.2 Europe Intravitreal (IVT) Injectables Revenue (2015-2020)
    • 4.3.3 Key Players in Europe
    • 4.3.4 Europe Intravitreal (IVT) Injectables Import & Export (2015-2020)
  • 4.4 China
    • 4.4.1 China Intravitreal (IVT) Injectables Production (2015-2020)
    • 4.4.2 China Intravitreal (IVT) Injectables Revenue (2015-2020)
    • 4.4.3 Key Players in China
    • 4.4.4 China Intravitreal (IVT) Injectables Import & Export (2015-2020)
  • 4.5 Japan
    • 4.5.1 Japan Intravitreal (IVT) Injectables Production (2015-2020)
    • 4.5.2 Japan Intravitreal (IVT) Injectables Revenue (2015-2020)
    • 4.5.3 Key Players in Japan
    • 4.5.4 Japan Intravitreal (IVT) Injectables Import & Export (2015-2020)

5 Intravitreal (IVT) Injectables Consumption by Region

  • 5.1 Global Top Intravitreal (IVT) Injectables Regions by Consumption
    • 5.1.1 Global Top Intravitreal (IVT) Injectables Regions by Consumption (2015-2020)
    • 5.1.2 Global Top Intravitreal (IVT) Injectables Regions Market Share by Consumption (2015-2020)
  • 5.2 North America
    • 5.2.1 North America Intravitreal (IVT) Injectables Consumption by Application
    • 5.2.2 North America Intravitreal (IVT) Injectables Consumption by Countries
    • 5.2.3 U.S.
    • 5.2.4 Canada
  • 5.3 Europe
    • 5.3.1 Europe Intravitreal (IVT) Injectables Consumption by Application
    • 5.3.2 Europe Intravitreal (IVT) Injectables Consumption by Countries
    • 5.3.3 Germany
    • 5.3.4 France
    • 5.3.5 U.K.
    • 5.3.6 Italy
    • 5.3.7 Russia
  • 5.4 Asia Pacific
    • 5.4.1 Asia Pacific Intravitreal (IVT) Injectables Consumption by Application
    • 5.4.2 Asia Pacific Intravitreal (IVT) Injectables Consumption by Regions
    • 5.4.3 China
    • 5.4.4 Japan
    • 5.4.5 South Korea
    • 5.4.6 India
    • 5.4.7 Australia
    • 5.4.8 Taiwan
    • 5.4.9 Indonesia
    • 5.4.10 Thailand
    • 5.4.11 Malaysia
    • 5.4.12 Philippines
    • 5.4.13 Vietnam
  • 5.5 Central & South America
    • 5.5.1 Central & South America Intravitreal (IVT) Injectables Consumption by Application
    • 5.5.2 Central & South America Intravitreal (IVT) Injectables Consumption by Country
    • 5.5.3 Mexico
    • 5.5.3 Brazil
    • 5.5.3 Argentina
  • 5.6 Middle East and Africa
    • 5.6.1 Middle East and Africa Intravitreal (IVT) Injectables Consumption by Application
    • 5.6.2 Middle East and Africa Intravitreal (IVT) Injectables Consumption by Countries
    • 5.6.3 Turkey
    • 5.6.4 Saudi Arabia
    • 5.6.5 U.A.E

6 Market Size by Type (2015-2026)

  • 6.1 Global Intravitreal (IVT) Injectables Market Size by Type (2015-2020)
    • 6.1.1 Global Intravitreal (IVT) Injectables Production by Type (2015-2020)
    • 6.1.2 Global Intravitreal (IVT) Injectables Revenue by Type (2015-2020)
    • 6.1.3 Intravitreal (IVT) Injectables Price by Type (2015-2020)
  • 6.2 Global Intravitreal (IVT) Injectables Market Forecast by Type (2021-2026)
    • 6.2.1 Global Intravitreal (IVT) Injectables Production Forecast by Type (2021-2026)
    • 6.2.2 Global Intravitreal (IVT) Injectables Revenue Forecast by Type (2021-2026)
    • 6.2.3 Global Intravitreal (IVT) Injectables Price Forecast by Type (2021-2026)
  • 6.3 Global Intravitreal (IVT) Injectables Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

7 Market Size by Application (2015-2026)

  • 7.2.1 Global Intravitreal (IVT) Injectables Consumption Historic Breakdown by Application (2015-2020)
  • 7.2.2 Global Intravitreal (IVT) Injectables Consumption Forecast by Application (2021-2026)

8 Corporate Profiles

  • 8.1 Regeneron Pharmaceuticals
    • 8.1.1 Regeneron Pharmaceuticals Corporation Information
    • 8.1.2 Regeneron Pharmaceuticals Overview and Its Total Revenue
    • 8.1.3 Regeneron Pharmaceuticals Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.1.4 Regeneron Pharmaceuticals Product Description
    • 8.1.5 Regeneron Pharmaceuticals Recent Development
  • 8.2 Bausch & Lomb
    • 8.2.1 Bausch & Lomb Corporation Information
    • 8.2.2 Bausch & Lomb Overview and Its Total Revenue
    • 8.2.3 Bausch & Lomb Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.2.4 Bausch & Lomb Product Description
    • 8.2.5 Bausch & Lomb Recent Development
  • 8.3 Novartis
    • 8.3.1 Novartis Corporation Information
    • 8.3.2 Novartis Overview and Its Total Revenue
    • 8.3.3 Novartis Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.3.4 Novartis Product Description
    • 8.3.5 Novartis Recent Development
  • 8.4 Allergan
    • 8.4.1 Allergan Corporation Information
    • 8.4.2 Allergan Overview and Its Total Revenue
    • 8.4.3 Allergan Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.4.4 Allergan Product Description
    • 8.4.5 Allergan Recent Development
  • 8.5 Alimera Sciences
    • 8.5.1 Alimera Sciences Corporation Information
    • 8.5.2 Alimera Sciences Overview and Its Total Revenue
    • 8.5.3 Alimera Sciences Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.5.4 Alimera Sciences Product Description
    • 8.5.5 Alimera Sciences Recent Development
  • 8.6 ThromboGenics
    • 8.6.1 ThromboGenics Corporation Information
    • 8.6.2 ThromboGenics Overview and Its Total Revenue
    • 8.6.3 ThromboGenics Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.6.4 ThromboGenics Product Description
    • 8.6.5 ThromboGenics Recent Development
  • 8.7 Bristol-Myers Squibb
    • 8.7.1 Bristol-Myers Squibb Corporation Information
    • 8.7.2 Bristol-Myers Squibb Overview and Its Total Revenue
    • 8.7.3 Bristol-Myers Squibb Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.7.4 Bristol-Myers Squibb Product Description
    • 8.7.5 Bristol-Myers Squibb Recent Development

9 Production Forecasts by Regions

  • 9.1 Global Top Intravitreal (IVT) Injectables Regions Forecast by Revenue (2021-2026)
  • 9.2 Global Top Intravitreal (IVT) Injectables Regions Forecast by Production (2021-2026)
  • 9.3 Key Intravitreal (IVT) Injectables Production Regions Forecast
    • 9.3.1 North America
    • 9.3.2 Europe
    • 9.3.3 China
    • 9.3.4 Japan

10 Intravitreal (IVT) Injectables Consumption Forecast by Region

  • 10.1 Global Intravitreal (IVT) Injectables Consumption Forecast by Region (2021-2026)
  • 10.2 North America Intravitreal (IVT) Injectables Consumption Forecast by Region (2021-2026)
  • 10.3 Europe Intravitreal (IVT) Injectables Consumption Forecast by Region (2021-2026)
  • 10.4 Asia Pacific Intravitreal (IVT) Injectables Consumption Forecast by Region (2021-2026)
  • 10.5 Latin America Intravitreal (IVT) Injectables Consumption Forecast by Region (2021-2026)
  • 10.6 Middle East and Africa Intravitreal (IVT) Injectables Consumption Forecast by Region (2021-2026)

11 Value Chain and Sales Channels Analysis

  • 11.1 Value Chain Analysis
  • 11.2 Sales Channels Analysis
    • 11.2.1 Intravitreal (IVT) Injectables Sales Channels
    • 11.2.2 Intravitreal (IVT) Injectables Distributors
  • 11.3 Intravitreal (IVT) Injectables Customers

12 Market Opportunities & Challenges, Risks and Influences Factors Analysis

  • 12.1 Market Opportunities and Drivers
  • 12.2 Market Challenges
  • 12.3 Market Risks/Restraints
  • 12.4 Porter's Five Forces Analysis

13 Key Finding in The Global Intravitreal (IVT) Injectables Study

    14 Appendix

    • 14.1 Research Methodology
      • 14.1.1 Methodology/Research Approach
      • 14.1.2 Data Source
    • 14.2 Author Details

    Summary:
    Get latest Market Research Reports on COVID-19 Impact on Global Intravitreal (IVT) Injectables. Industry analysis & Market Report on COVID-19 Impact on Global Intravitreal (IVT) Injectables is a syndicated market report, published as COVID-19 Impact on Global Intravitreal (IVT) Injectables Market Insights, Forecast to 2026. It is complete Research Study and Industry Analysis of COVID-19 Impact on Global Intravitreal (IVT) Injectables market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $4,900.00
    $7,350.00
    $9,800.00
    3,905.30
    5,857.95
    7,810.60
    4,571.70
    6,857.55
    9,143.40
    765,674.00
    1,148,511.00
    1,531,348.00
    409,003.00
    613,504.50
    818,006.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report